Thangaraju P - Search Results

1

Author Correction: Hybrid CNN-LSTM model with efficient hyperparameter tuning for prediction of Parkinson's disease.

Lilhore UK, Dalal S, Faujdar N, Margala M, Chakrabarti P, Chakrabarti T, Simaiya S, Kumar P, Thangaraju P, Velmurugan H. Lilhore UK, et al. Among authors: thangaraju p. Sci Rep. 2024 Apr 23;14(1):9335. doi: 10.1038/s41598-024-59648-6. Sci Rep. 2024. PMID: 38653768 Free PMC article. No abstract available.

2

Sleep-walking a rarest side effect of zolpidem.

Singh H, Thangaraju P, Natt NK. Singh H, et al. Among authors: thangaraju p. Indian J Psychol Med. 2015 Jan-Mar;37(1):105-6. doi: 10.4103/0253-7176.150856. Indian J Psychol Med. 2015. PMID: 25722525 Free PMC article.

3

Prevalence of leptospiral agglutinins among conservancy workers in Madras City, India.

Ratnam S, Everard CO, Alex JC, Suresh B, Thangaraju P. Ratnam S, et al. Among authors: thangaraju p. J Trop Med Hyg. 1993 Feb;96(1):41-5. J Trop Med Hyg. 1993. PMID: 8429573

4

Does Remdesivir maintain the race in the general treatment protocol of COVID-19?

Thangaraju P, Velmurugan H. Thangaraju P, et al. J Family Med Prim Care. 2021 Dec;10(12):4621-4622. doi: 10.4103/jfmpc.jfmpc_1552_21. Epub 2021 Dec 27. J Family Med Prim Care. 2021. PMID: 35280619 Free PMC article. No abstract available.

5

Paediatric dosage 'need of hours among family physicians/other speciality physicians'.

Thangaraju P, Velmurugan H, Venkatesan S, Sudha TYS. Thangaraju P, et al. J Family Med Prim Care. 2022 Apr;11(4):1593-1594. doi: 10.4103/jfmpc.jfmpc_97_22. Epub 2022 Mar 18. J Family Med Prim Care. 2022. PMID: 35516703 Free PMC article. No abstract available.

6

Capecitabine and Hand-foot Syndrome: A Case Report.

Uppala PK, Varghese AM, Yella SST, Velmurugan H, Thangaraju P, Krishna Sasanka KSBS. Uppala PK, et al. Among authors: thangaraju p. Infect Disord Drug Targets. 2023;23(1):e140622205973. doi: 10.2174/1871526522666220614162117. Infect Disord Drug Targets. 2023. PMID: 35708076

7

Vigilance Needed in Treating Leprosy Patients in Accordance with WHO's AWaRe.

Thangaraju P, Velmurugan H, Yella SST, Venkatesan S. Thangaraju P, et al. Recent Adv Antiinfect Drug Discov. 2022;17(2):95-102. doi: 10.2174/2772434417666220720111849. Recent Adv Antiinfect Drug Discov. 2022. PMID: 35864797 Review.

8

Leprosy Reactions: Clinical Pharmacologist Perspective with Repurposed Medications.

Thangaraju P, Balan AK, Velmurugan H, Venkatesan S, Yella SST. Thangaraju P, et al. Infect Disord Drug Targets. 2023;23(2):e070922208607. doi: 10.2174/1871526522666220907125114. Infect Disord Drug Targets. 2023. PMID: 36082854

9

Diligence needed on treatment of primary multidrug-resistant pulmonary tuberculosis with concomitant COVID-19 infection.

Thangaraju P, Velmurugan H. Thangaraju P, et al. J Family Med Prim Care. 2022 Jun;11(6):3391-3392. doi: 10.4103/jfmpc.jfmpc_2324_21. Epub 2022 Jun 30. J Family Med Prim Care. 2022. PMID: 36119304 Free PMC article. No abstract available.

10

Time to be vigilant in contacts of leprosy for possible single-dose rifampicin.

Thangaraju P, Velmurugan H, Neelambaran K, Venkatesan S. Thangaraju P, et al. JAAD Case Rep. 2022 Nov;29:100-101. doi: 10.1016/j.jdcr.2022.05.014. Epub 2022 May 25. JAAD Case Rep. 2022. PMID: 36212896 Free PMC article. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

136 results

Search Page